Log in

Relevant bibliographies by topics / Diseases therapy / Journal articles

To see the other types of publications on this topic, follow the link: Diseases therapy.

Journal articles on the topic 'Diseases therapy'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Diseases therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Topolyanskaya, Topolyanskaya S. V. "Hyperuricemia and cardiovascular diseases." Therapy 7_2020 (October 26, 2020): 71–82. http://dx.doi.org/10.18565/therapy.2020.7.71-82.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

ISHIKAWA, KINJI. "Internal medicine diseases and anti-thrombotic therapy. Anti-thrombotic therapy for arteriosclerotic diseases. Ischemic heart diseases ( antiplatelet therapy )." Nihon Naika Gakkai Zasshi 86, no. 9 (1997): 1621–24. http://dx.doi.org/10.2169/naika.86.1621.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

KANMATSUSE, KATSUO. "Internal medicine diseases and anti-thrombotic therapy. Anti-thrombotic therapy for arteriosclerotic diseases. Ischemic heart diseases ( thrombolytic therapy )." Nihon Naika Gakkai Zasshi 86, no. 9 (1997): 1625–28. http://dx.doi.org/10.2169/naika.86.1625.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Eliseev, Eliseev M. S. "Cardiovascular diseases in gout and urate-lowering therapy." Therapy 1_2021 (February 19, 2021): 108–15. http://dx.doi.org/10.18565/therapy.2021.1.108-115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Vertkin, Vertkin A. L., and Evsyukova M. V. Evsyukova. "Orphan diseases in outpatient therapeutic practice." Therapy 6_2022 (September 23, 2022): 54–63. http://dx.doi.org/10.18565/therapy.2022.6.54-63.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Gorbunova, Victoria N. "Congenital metabolic diseases. Lysosomal storage diseases." Pediatrician (St. Petersburg) 12, no. 2 (2021): 73–83. http://dx.doi.org/10.17816/ped12273-83.

Full text

Abstract:

The classification and epidemiology of hereditary metabolic disorders are presented. That is a large group consisting from more them 800 monogenic diseases, each of which caused by inherited deficiency of certain metabolic fate. Many of these disorders are extremely rare, but their total incidence in the population is close to 1:10005000. Lysosomal storage diseases (LSD) resulting from inherited deficiency in lysosomal functions occupy a special place among hereditary metabolic disorders. The defects of catabolism cause the accumulation of undigested or partially digested macromolecules in lys

APA, Harvard, Vancouver, ISO, and other styles

7

Blum, Hubert E. "Gene Therapy Liver Diseases." Kanzo 41, supl2 (2000): A300—A301. http://dx.doi.org/10.2957/kanzo.41.supl2_a300.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Forloni, Gianluigi, Vladimiro Artuso, Ignazio Roiter, Michela Morbin, and Fabrizio Tagliavini. "Therapy in Prion Diseases." Current Topics in Medicinal Chemistry 13, no. 19 (2013): 2465–76. http://dx.doi.org/10.2174/15680266113136660173.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Schrank, John. "Therapy of Infectious Diseases." Mayo Clinic Proceedings 78, no. 10 (2003): 1316. http://dx.doi.org/10.4065/78.10.1314-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Miller, P. "Therapy for genetic diseases." Biochemical Education 19, no. 4 (1991): 220. http://dx.doi.org/10.1016/0307-4412(91)90112-l.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Matloff, Daniel S. "Therapy in liver diseases." Gastroenterology 103, no. 4 (1992): 1365. http://dx.doi.org/10.1016/0016-5085(92)91536-d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Talan, David A., and Gregory J. Moran. "Infectious Diseases: Antimicrobial Therapy." Academic Emergency Medicine 1, no. 2 (2008): 180–82. http://dx.doi.org/10.1111/j.1553-2712.1994.tb02757.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Abrutyn, Elias. "Therapy of Infectious Diseases." Annals of Internal Medicine 139, no. 7 (2003): 606. http://dx.doi.org/10.7326/0003-4819-139-7-200310070-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Linke, Reinhold P. "Therapy of Amyloid Diseases." Renal Failure 15, no. 3 (1993): 395–400. http://dx.doi.org/10.3109/08860229309054951.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

WATANABE, MAMORU. "Therapy of inflammatory immune diseases. 1) Leukocytapheresis therapy for inflammatory immune diseases." Nihon Naika Gakkai Zasshi 95, no. 9 (2006): 1775–80. http://dx.doi.org/10.2169/naika.95.1775.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Avdeeva, Avdeeva I. V., Burko N. V. Burko, Makarova Kar N. Makarova, Makarova Kr N. Makarova, and Oleynikov V. E. Oleynikov. "COVID-19 and cardiovascular diseases: a dangerous tandem." Therapy 5_2021 (June 21, 2021): 96–102. http://dx.doi.org/10.18565/therapy.2021.5.96-102.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Nasonov, Nasonov E. L. "Pharmacotherapy of immuno-inflammatory rheumatic diseases: new opportunities." Therapy 6_2019 (November 1, 2019): 151–62. http://dx.doi.org/10.18565/therapy.2019.6.151-162.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Klemenov, Klemenov A. V. "Management of patients with allergic diseases during pregnancy." Therapy 9_2022 (December 12, 2022): 101–6. http://dx.doi.org/10.18565/therapy.2022.9.101-106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Korzhavina, V. B. Korzhavina. "Basis of propaedeutics of nervous diseases." Therapy 7-8_2018 (December 25, 2018): 25–31. http://dx.doi.org/10.18565/therapy.2018.7-8.25-31.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Kozlova, Kozlova I. V., Kudishina M. M. Kudishina, Bykova A. P. Bykova, and Krylova Yu S. Krylova. "Pathology of the musculoskeletal system in inflammatory bowel diseases." Therapy 7_2021 (October 15, 2021): 50–57. http://dx.doi.org/10.18565/therapy.2021.7.50-57.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Polunina, Polunina Т. E. "Therapeutic approaches to the treatment of hepar cholestatic diseases." Therapy 3_2019 (July 22, 2019): 99–108. http://dx.doi.org/10.18565/therapy.2019.3.99-108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Rukavishnikov, Rukavishnikov G. V., Neznanov N. G. Neznanov, Martynov A. I. Martynov, and Mazo G. E. Mazo. "Treatment of depression in patients with comorbid somatic diseases." Therapy 3_2020 (May 14, 2020): 76–83. http://dx.doi.org/10.18565/therapy.2020.3.76-83.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

YOSHIKAWA, Toshikazu, Yuji NAITO, and Motoharu KONDO. "Antioxidant Therapy in Digestive Diseases." Journal of Nutritional Science and Vitaminology 39, Supplement (1993): S35—S41. http://dx.doi.org/10.3177/jnsv.39.supplement_s35.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Chandler, Randy J., and Charles P. Venditti. "Gene therapy for metabolic diseases." Translational Science of Rare Diseases 1, no. 1 (2016): 73–89. http://dx.doi.org/10.3233/trd-160007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Lee, Eun Jig, and J. Larry Jameson. "Gene therapy of pituitary diseases." Journal of Endocrinology 185, no. 3 (2005): 353–62. http://dx.doi.org/10.1677/joe.1.06023.

Full text

Abstract:

Despite a stuttering course, gene therapy continues to provide a potential treatment avenue for many human diseases, including cancer and various inherited disorders. Gene therapy is also attractive for the treatment of local, benign disorders, such as pituitary adenomas. Advances in technology have focused on modifying existing viral vectors and developing targeted expression of therapeutic genes in an effort to achieve efficacy with minimal toxicity. Gene therapy also offers innovative strategies for treating hypopituitarism by replacing hormones such as growth hormone (GH) and vasopressin.

APA, Harvard, Vancouver, ISO, and other styles

26

ISHIBASHI, YASUMASA. "Retinoid therapy for skin diseases." Nishi Nihon Hifuka 48, no. 6 (1986): 1045–49. http://dx.doi.org/10.2336/nishinihonhifu.48.1045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Samiy, Nasrollah. "Gene therapy for retinal diseases." Journal of Ophthalmic and Vision Research 9, no. 4 (2014): 506. http://dx.doi.org/10.4103/2008-322x.150831.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

MASUDA, Haruchika, and Hajime TSUJI. "Gene Therapy for Thrombotic Diseases." Japanese Journal of Thrombosis and Hemostasis 6, no. 1 (1995): 31–35. http://dx.doi.org/10.2491/jjsth.6.31.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Tomescu, Aneta, Rodica Sîrbu, Stelian Paris, Emin Cadar, Cristina Luiza Erimia, and Cezar Laurentiu Tomescu. "Methotrexate Therapy in Obstetricaĺ Diseases." European Journal of Interdisciplinary Studies 2, no. 1 (2016): 9. http://dx.doi.org/10.26417/ejis.v2i1.p9-16.

Full text

Abstract:

Our study is a rewiew of Methotrexate therapy in obstetrica? diseases such us: hydatidiform mole, and medical abortion. In the medical world, methotrexate is a citostatic drug used in neoplastic diseases. The clinical pharmacology data regarding methotrexate is presented, alongside route of administration and therapeutic effects in malignant disease, hydatiform mole, and medical abortion. The use of methotrexate in medical abortion and ectopic pregnancy is a great accomplishment, as it replaces a surgical intervention marred by characteristic side effects, with similar results.

APA, Harvard, Vancouver, ISO, and other styles

30

Tomescu, Aneta, Rodica Sîrbu, Stelian Paris, Emin Cadar, Cristina Luiza Erimia, and Cezar Laurentiu Tomescu. "Methotrexate Therapy in Obstetricaĺ Diseases." European Journal of Interdisciplinary Studies 4, no. 1 (2016): 9. http://dx.doi.org/10.26417/ejis.v4i1.p9-16.

Full text

Abstract:

Our study is a rewiew of Methotrexate therapy in obstetrica? diseases such us: hydatidiform mole, and medical abortion. In the medical world, methotrexate is a citostatic drug used in neoplastic diseases. The clinical pharmacology data regarding methotrexate is presented, alongside route of administration and therapeutic effects in malignant disease, hydatiform mole, and medical abortion. The use of methotrexate in medical abortion and ectopic pregnancy is a great accomplishment, as it replaces a surgical intervention marred by characteristic side effects, with similar results.

APA, Harvard, Vancouver, ISO, and other styles

31

NISHIMOTO, Norihiro, Tadamitsu KISHIMOTO, and Kazuyuki YOSHIZAKI. "Anticytokine Therapy in Autoimmune Diseases." Internal Medicine 38, no. 2 (1999): 178–82. http://dx.doi.org/10.2169/internalmedicine.38.178.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Golledge, Clayton L., and Thomas V. Riley. "“Natural” therapy for infectious diseases." Medical Journal of Australia 164, no. 2 (1996): 94–95. http://dx.doi.org/10.5694/j.1326-5377.1996.tb101359.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Hara, Kohei. "Targeting therapy in infectious diseases." Drug Delivery System 4, no. 2 (1989): 61–62. http://dx.doi.org/10.2745/dds.4.61.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

FUKASAWA, Hiroshi, Hiroyuki KAGECHIKA, and Koichi SHUDO. "Retinoid Therapy for Autoimmune Diseases." Japanese Journal of Clinical Immunology 29, no. 3 (2006): 114–26. http://dx.doi.org/10.2177/jsci.29.114.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Gruchala, Marcin, Himadri Roy, Shalini Bhardwaj, and Seppo Yla-Herttuala. "Gene Therapy for Cardiovascular Diseases." Current Pharmaceutical Design 10, no. 4 (2004): 407–23. http://dx.doi.org/10.2174/1381612043453379.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Kim, Jun Young, Il Sup Kim, Jae Taek Hong, Jae Yeol Kwon, Jae Hoon Sung, and Sang Won Lee. "Laser Therapy for Spinal Diseases." Asian Journal of Pain 1, no. 1 (2015): 6–9. http://dx.doi.org/10.35353/ajp.1.1.6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

OKAMURA, HIROSHI. "Laser therapy of laryngeal diseases." Practica Oto-Rhino-Laryngologica 79, no. 5 (1986): 697–99. http://dx.doi.org/10.5631/jibirin.79.697.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Rice, Claire, Christopher Halfpenny, and Neil Scolding. "Cell therapy in demyelinating diseases." NeuroRX 1, no. 4 (2004): 415–23. http://dx.doi.org/10.1602/neurorx.1.4.415.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Tateno, Kaoru, Tohru Minamino, Junji Moriya, et al. "Cell Therapy for Cardiovascular Diseases." Annals of Vascular Diseases 1, no. 2 (2008): 66–79. http://dx.doi.org/10.3400/avd.avdsr00108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Cavic, Milena, Ana Krivokuca, Radmila Jankovic, and Sinisa Radulovic. "Personalized therapy of malignant diseases." Pirotski zbornik, no. 40 (2015): 69–79. http://dx.doi.org/10.5937/pirotzbor1540069c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

MORI, Keisuke, and Shin YONEYA. "Photodynamic Therapy for Ocular Diseases." JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE 18, no. 3 (1997): 31–36. http://dx.doi.org/10.2530/jslsm1980.18.3_31.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Wu, George Y., and Catherine H. Wu. "Gene therapy and liver diseases." World Journal of Gastroenterology 4, no. 2 (1998): 16. http://dx.doi.org/10.3748/wjg.v4.isuppl2.16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

O., V. "Mud therapy for surgical diseases." Kazan medical journal 22, no. 2 (2020): 241. http://dx.doi.org/10.17816/kazmj52911.

Full text

Abstract:

Prof. VI Razumovsky (Med. Sat. Kavk. Min. V., issue 2, 1925), considers the following surgical diseases to be indicative of mud therapy; first of all, various forms of articular diseases, especially rheumatic ones with a chronic course, intra-articular and periarticular exudates, pain, stiffness, etc., as well as non-started gouty (on the contrary, infectious and toxic forms are more difficult to treat with mud), then chronic osteomyelitis and their consequences , thrombophlebitis (especially of gouty origin), consequences of varicose processes (dermatitis, leg ulcers, etc.), consequences of i

APA, Harvard, Vancouver, ISO, and other styles

44

Klyachkin, G. "Protein therapy for nervous diseases." Kazan medical journal 20, no. 1 (2021): 102. http://dx.doi.org/10.17816/kazmj76198.

Full text

Abstract:

Nading (Bp. Gaz., 1923, nos. 19-20), having applied milk treatment for various sufferings of the nervous system, both central and peripheral, found that in epilepsy and epidemic encephalitis it did not give any results.

APA, Harvard, Vancouver, ISO, and other styles

45

Ivanov, S. V., and E. I. Voronova. "Depression therapy for somatic diseases." Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121, no. 5 (2021): 106. http://dx.doi.org/10.17116/jnevro2021121052106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Rivellese, Mark J., and Caroline R. Baumal. "Photodynamic Therapy of Eye Diseases." Ophthalmic Surgery, Lasers and Imaging Retina 30, no. 8 (1999): 653–61. http://dx.doi.org/10.3928/1542-8877-19990901-09.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Gutiérrez, Beatriz, and Pilar Domingo-Calap. "Phage Therapy in Gastrointestinal Diseases." Microorganisms 8, no. 9 (2020): 1420. http://dx.doi.org/10.3390/microorganisms8091420.

Full text

Abstract:

Gastrointestinal tract microbiota plays a key role in the regulation of the pathogenesis of several gastrointestinal diseases. In particular, the viral fraction, composed essentially of bacteriophages, influences homeostasis by exerting a selective pressure on the bacterial communities living in the tract. Gastrointestinal inflammatory diseases are mainly induced by bacteria, and have risen due to the emergence of antibiotic resistant strains. In the lack of effective treatments, phage therapy has been proposed as a clinical alternative to restore intestinal eubiosis, thanks to its immunomodul

APA, Harvard, Vancouver, ISO, and other styles

48

Kohn, Donald B., W. French Anderson, and R. Michael Blaese. "Gene Therapy for Genetic Diseases." Cancer Investigation 7, no. 2 (1989): 179–92. http://dx.doi.org/10.3109/07357908909038283.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Ignatova, G. L., and V. N. Antonov. "Nebulizer therapy for lung diseases." Meditsinskiy sovet = Medical Council, no. 11 (August 8, 2020): 102–6. http://dx.doi.org/10.21518/2079-701x-2020-11-102-106.

Full text

Abstract:

The article presents data on the use of nebulizer therapy for major respiratory diseases: chronic obstructive pulmonary disease (COPD), bronchial asthma. The conditions for using aerosol-producing devices for new COVID-19 coronavirus infection, in the hospital and at home are also given. Historical aspects of the creation and use of devices for nebulizer therapy are considered. A differentiated approach is given when choosing an inhaler depending on the clinical situation, taking into account the need to use devices with a high level of precipitated fine particle fraction of the pharmaceutical

APA, Harvard, Vancouver, ISO, and other styles

50

Ruiz-Moreno, José Mª, and Javier A. Montero. "Photodynamic therapy in macular diseases." Expert Review of Ophthalmology 1, no. 1 (2006): 97–112. http://dx.doi.org/10.1586/17469899.1.1.97.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!